Related Experiment Video
Updated: Oct 10, 2025

09:51
Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
Published on: March 3, 2020
9.3K
Phase-Changing Glauber Salt Solution for Medical Applications in the 28-32 °C Interval
Linus Olson1,2, Carina Lothian3, Ulrika Ådén1
1Department of Women's and Children's Health, Karolinska Institutet, 17177 Stockholm, Sweden.
Materials (Basel, Switzerland)
|December 10, 2021
Summary
Researchers developed a novel Glauber salt solution, a simple phase change material (PCM), for neonatal cooling. This innovation provides effective mild hypothermia for asphyxiated infants, especially in low-resource settings.
Area of Science:
- Materials Science
- Medical Engineering
- Pediatrics
Background:
- Medical applications require simple cooling materials, particularly phase change materials (PCMs) between 28-40°C.
- Induced mild hypothermia is crucial for treating birth asphyxia in infants, but current methods are resource-intensive.
- Neonatal cooling is vital in low-resource settings where birth asphyxia causes significant mortality.
Purpose of the Study:
- To develop a simple, safe, and effective cooling material for medical use within the 28-37.5°C range.
- To address the need for accessible hypothermia treatment for asphyxiated newborns.
Main Methods:
- Empirical experiments were conducted to modify Glauber salt ingredients.
- The temperature-dependent behavior of various NaCl, Na2SO4, and water mixtures was investigated.
- Controlled examinations were performed to understand mixture properties and optimize for clinical specifications.
Main Results:
- A deeper understanding of how different salt mixtures function within the target temperature range was achieved.
- Optimized salt solutions were identified that meet clinical cooling requirements.
- The developed Glauber salt solution demonstrated suitability as a phase change material for neonatal cooling.
Conclusions:
- The Glauber salt solution is a clinically appropriate phase change material for the temperature range required for cooling asphyxiated infants.
- This PCM offers a promising, low-resource solution for neonatal therapeutic hypothermia.
- The study provides a foundation for further development of accessible medical cooling technologies.
Keywords:
glauber salthypoxic ischemic encephalopathyneonatal asphyxiaphase change materialtherapeutic hypothermia
